Cost Per Responder of Lixisenatide Versus Rapid-Acting Insulin Intensification Regimens in an Insulin-Exposed Type 2 Diabetes Mellitus (T2DM) Population
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.1866
https://www.valueinhealthjournal.com/article/S1098-3015(16)33232-6/fulltext
Title :
Cost Per Responder of Lixisenatide Versus Rapid-Acting Insulin Intensification Regimens in an Insulin-Exposed Type 2 Diabetes Mellitus (T2DM) Population
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33232-6&doi=10.1016/j.jval.2016.09.1866
First page :
A671
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1766